For the Inventor, By the Inventor

Enter assignee name

Princeton, NJ, United States of America

Bristol-Myers Squibb Pharma Company

USPTO Granted Patents = 234

CIPO Patents = 1

EPO Patents = 2

Trademarks = 6

Forward Citations = 3,397

Loading Chart...

Loading Chart...

235 inventors (with patents filed for the assignee):

Richard Eric Olson (27 out of 108 patents)

John V Duncia (21 out of 55 patents)

Dean A Wacker (21 out of 50 patents)

4. Milind Rajopadhye (20 out of 43 patents)

5. Mimi Lifen Quan (19 out of 82 patents)

6. Joseph B Santella (18 out of 50 patents)

7. Soo Sung Ko (17 out of 41 patents)

8. Shuang Liu (16 out of 67 patents)

9. George V DeLucca (16 out of 20 patents)

10. Paul Joseph Gilligan (14 out of 47 patents)

11. Lorin Andrew Thompson (13 out of 18 patents)

12. Thomas David Harris (13 out of 32 patents)

13. Donald J P Pinto (12 out of 78 patents)

14. Jingwu Duan (12 out of 52 patents)

15. Michael G Yang (12 out of 47 patents)

Core Competencies:

Benzodiazepines

Corticotropin Releasing Factor Ligands

Chemokine Receptor Modulators

Lactam Inhibitors

Pyrazolo Triazines

Vitronectin Receptor Antagonists

Matrix Metalloproteinase Inhibitors

Small Molecule Radioligands

Acylsemicarbazides

Substituted Heterocycles

Cyclic Malonamides

Contrast Agents

234 patents: Sort by Forward Citations

1. 7718795 - Succinoylamino benzodiazepines as inhibitors of aβ protein production (2010-05-18),

2. 7678793 - Azolo triazines and pyrimidines (2010-03-16),

3. 7662817 - 4-(2-Butylamino)-2,7-dimethyl-8-(2-methyl-6-methoxypyrid-3-yl)pyrazolo-[1,5-A]-1,3,5-triazine, its enantiomers and pharmaceutically acceptable salts as corticotropin releasing factor receptor ligands (2010-02-16),

4. 7655647 - Substituted lactams as inhibitors of Aβ protein production (2010-02-02),

5. 7528249 - Cyclic malonamides as inhibitors of aβ protein production (2009-05-05),

6. 7514430 - Piperizinones as modulators of chemokine receptor activity (2009-04-07),

7. 7507815 - Succinoylamino lactams as inhibitors of a-β protein production (2009-03-24),

8. 7498324 - Substituted lactams as inhibitors of Aβ protein production (2009-03-03),

9. 7456172 - Succinoylamino benzodiazepines as inhibitors of Aβ protein production (2008-11-25),

10. 7449493 - Diamines as modulators of chemokine receptor activity (2008-11-11),

11. 7442792 - Process for the preparation of pyrazolo[1,5-a]-1,3,5-triazines and intermediates thereof (2008-10-28),

12. 7423033 - Hydroxyalkanoylaminolactams and related structures as inhibitors of aβ protein production (2008-09-09),

13. 7358252 - 4-(2-butylamino)-2,7-dimethyl-8-(2-methyl-6-methoxypyrid-3-yl)pyrazolo-[1,5-a]-1,3,5-triazine, its enantiomers and pharmaceutically acceptable salts as corticotropin releasing factor receptor ligands (2008-04-15),

14. 7354914 - Lactams substituted by cyclic succinates as inhibitors of Aβ protein production (2008-04-08),

15. 7344702 - Contrast agents for myocardial perfusion imaging (2008-03-18),

Bristol-Myers Squibb is a global biopharmaceutical company that discovers, develops, and delivers innovative medicines for patients with serious diseases. With a diverse portfolio of drugs and a focus on areas such as oncology, immunology, cardiovascular, and fibrosis, Bristol-Myers Squibb aims to transform patients' lives through scientific advancements.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

234 Patents

#11 in Princeton, NJ

#85 in New Jersey

#1,723 in US

#3,552 in the World

Princeton, NJ, United States of America

Bristol-Myers Squibb Pharma Company

Forward Citations = 3,397

235 inventors:

Richard Eric Olson (27 out of 108 patents)

John V Duncia (21 out of 55 patents)

Dean A Wacker (21 out of 50 patents)

4. Milind Rajopadhye (20 out of 43 patents)

5. Mimi Lifen Quan (19 out of 82 patents)

Please report any incorrect information to support@idiyas.com

Loading…